Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Clin Epidemiol. 2006 Aug;59(8):808-18. Epub 2006 Mar 15.

Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations.

Author information

  • 1Clinical Research Unit, Kaiser Permanente, P. O. Box 378006, Colorado, Denver, CO 80237-8066, USA. jason.m.glanz@kp.org

Abstract

OBJECTIVE:

We conducted a simulation study to empirically compare four study designs [cohort, case-control, risk-interval, self-controlled case series (SCCS)] used to assess vaccine safety.

STUDY DESIGN AND METHODS:

Using Vaccine Safety Datalink data (a Centers for Disease Control and Prevention-funded project), we simulated 250 case sets of an acute illness within a cohort of vaccinated and unvaccinated children. We constructed the other three study designs from the cohort at three different incident rate ratios (IRRs, 2.00, 3.00, and 4.00), 15 levels of decreasing disease incidence, and two confounding levels (20%, 40%) for both fixed and seasonal confounding. Each of the design-specific study samples was analyzed with a regression model. The design-specific beta; estimates were compared.

RESULTS:

The beta; estimates of the case-control, risk-interval, and SCCS designs were within 5% of the true risk parameters or cohort estimates. However, the case-control's estimates were less precise, less powerful, and biased by fixed confounding. The estimates of SCCS and risk-interval designs were biased by unadjusted seasonal confounding.

CONCLUSIONS:

All the methods were valid designs, with contrasting strengths and weaknesses. In particular, the SCCS method proved to be an efficient and valid alternative to the cohort method.

PMID:
16828674
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk